{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:00:49Z","timestamp":1790067649598,"version":"4.0.1"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["CGSD3-567941-2022"],"award-info":[{"award-number":["CGSD3-567941-2022"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016872","name":"Massachusetts Institute of Technology Koch Institute for Integrative Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016872","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006919","name":"Massachusetts Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006919","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["5P30-CA014051"],"award-info":[{"award-number":["5P30-CA014051"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F30DK130564"],"award-info":[{"award-number":["F30DK130564"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM007753"],"award-info":[{"award-number":["T32GM007753"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM144273"],"award-info":[{"award-number":["T32GM144273"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001068","name":"Dana Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001068","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.mtbio.2026.103251","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T23:43:14Z","timestamp":1779493394000},"page":"103251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Polyelectrolyte nanoparticles enable intracellular delivery of STING protein fragments for ovarian cancer immunotherapy"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9046-4383","authenticated-orcid":false,"given":"Justin A.","family":"Kaskow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altaf","family":"Bacchus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1122-0482","authenticated-orcid":false,"given":"Victoria F.","family":"Gomerdinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3813-8684","authenticated-orcid":false,"given":"Adam G.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6342-3324","authenticated-orcid":false,"given":"Ze-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Gerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1141-3938","authenticated-orcid":false,"given":"Mellany A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1280-077X","authenticated-orcid":false,"given":"Julia","family":"Treese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan","family":"Kindopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5711-8210","authenticated-orcid":false,"given":"Daniela M.","family":"Dinulescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Barbie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9835-192X","authenticated-orcid":false,"given":"Paula T.","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7213","key":"10.1016\/j.mtbio.2026.103251_bib1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling","volume":"455","author":"Ishikawa","year":"2008","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.mtbio.2026.103251_bib2","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.immuni.2008.09.003","article-title":"The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation","volume":"29","author":"Zhong","year":"2008","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.mtbio.2026.103251_bib3","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.mtbio.2026.103251_bib4","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.4049\/jimmunol.1401869","article-title":"STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells","volume":"193","author":"Klarquist","year":"2014","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103251_bib5","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.mtbio.2026.103251_bib6","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1016\/j.celrep.2018.11.047","article-title":"Magnitude of therapeutic STING activation determines CD8+ T cell-mediated anti-tumor immunity","volume":"25","author":"Sivick","year":"2018","journal-title":"Cell Rep."},{"issue":"283","key":"10.1016\/j.mtbio.2026.103251_bib7","doi-asserted-by":"crossref","first-page":"283ra52","DOI":"10.1126\/scitranslmed.aaa4306","article-title":"STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade","volume":"7","author":"Fu","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103251_bib8","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1158\/2326-6066.CIR-17-0263","article-title":"TNF\u03b1 and radioresistant stromal cells are essential for therapeutic efficacy of cyclic dinucleotide STING agonists in nonimmunogenic tumors","volume":"6","author":"Francica","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103251_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/2326-6066.CIR-21-0247","article-title":"Neoadjuvant STING activation, extended half-life IL2, and checkpoint blockade promote metastasis clearance via sustained NK-Cell activation","volume":"10","author":"Milling","year":"2022","journal-title":"Cancer Immunol. Res."},{"issue":"50","key":"10.1016\/j.mtbio.2026.103251_bib10","doi-asserted-by":"crossref","first-page":"15408","DOI":"10.1073\/pnas.1512832112","article-title":"STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity","volume":"112","author":"Demaria","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7736","key":"10.1016\/j.mtbio.2026.103251_bib11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","article-title":"Design of amidobenzimidazole STING receptor agonists with systemic activity","volume":"564","author":"Ramanjulu","year":"2018","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.mtbio.2026.103251_bib12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1078-0432.CCR-21-1963","article-title":"Phase I dose-escalation trial of MIW815 (ADU-S100), an intratumoral STING agonist, in patients with advanced\/metastatic solid tumors or lymphomas","volume":"28","author":"Meric-Bernstam","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103251_bib13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1078-0432.CCR-22-2235","article-title":"Combination of the STING agonist MIW815 (ADU-S100) and PD-1 inhibitor spartalizumab in advanced\/metastatic solid tumors or lymphomas: an open-label, multicenter, phase Ib study","volume":"29","author":"Meric-Bernstam","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103251_bib14","doi-asserted-by":"crossref","first-page":"viii712","DOI":"10.1093\/annonc\/mdy424.015","article-title":"LBA15 - preliminary results of the first-in-human (FIH) study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with pembrolizumab (pembro) in patients with advanced solid tumors or lymphomas","volume":"29","author":"Harrington","year":"2018","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103251_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11912-023-01361-0","article-title":"The development of STING agonists and emerging results as a cancer immunotherapy","volume":"25","author":"Hines","year":"2023","journal-title":"Curr. Oncol. Rep."},{"issue":"Suppl 1","key":"10.1016\/j.mtbio.2026.103251_bib16","article-title":"618 phase 1 clinical trial evaluating the safety, biologic and anti-tumor activity of the novel STING agonist IMSA101 administered both as monotherapy and in combination with PD-(L)1 checkpoint inhibitors","volume":"11","author":"Moser","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"15","key":"10.1016\/j.mtbio.2026.103251_bib17","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41388-017-0120-0","article-title":"Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production","volume":"37","author":"Konno","year":"2018","journal-title":"Oncogene"},{"issue":"22","key":"10.1016\/j.mtbio.2026.103251_bib18","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1158\/0008-5472.CAN-16-1404","article-title":"Recurrent loss of STING signaling in melanoma correlates with susceptibility to viral oncolysis","volume":"76","author":"Xia","year":"2016","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103251_bib19","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1158\/1541-7786.MCR-18-0504","article-title":"Ovarian cancer cells commonly exhibit defective STING signaling which affects sensitivity to viral oncolysis","volume":"17","author":"de Queiroz","year":"2019","journal-title":"Mol. Cancer Res."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103251_bib20","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jid.2021.08.437","article-title":"EZH2 inhibitor enhances the STING agonist\u2012induced antitumor immunity in melanoma","volume":"142","author":"Xu","year":"2022","journal-title":"J. Invest. Dermatol."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103251_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2006134","article-title":"KDM5 histone demethylases repress immune response via suppression of STING","volume":"16","author":"Wu","year":"2018","journal-title":"PLoS Biol."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103251_bib22","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.celrep.2015.12.029","article-title":"Deregulation of STING signaling in colorectal carcinoma constrains DNA damage responses and correlates with tumorigenesis","volume":"14","author":"Xia","year":"2016","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103251_bib23","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/s41467-023-37217-1","article-title":"Epigenetic state determines the in vivo efficacy of STING agonist therapy","volume":"14","author":"Falahat","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103251_bib24","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.bbrc.2016.09.021","article-title":"STING in tumor and host cells cooperatively work for NK cell-mediated tumor growth retardation","volume":"478","author":"Takashima","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"102","key":"10.1016\/j.mtbio.2026.103251_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adk7812","article-title":"Antigen-presenting cell activation requires intrinsic and extrinsic STING signaling after the phagocytosis of DNA-damaged cells","volume":"9","author":"Park","year":"2024","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103251_bib26","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1038\/s41467-024-49932-4","article-title":"Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responses","volume":"15","author":"Malli Cetinbas","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2026.103251_bib27","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.molimm.2023.10.003","article-title":"Resveratrol induces major histocompatibility complex class I antigen presentation in a STING-dependent and independent manner in melanoma","volume":"163","author":"Morehead","year":"2023","journal-title":"Mol. Immunol."},{"issue":"11","key":"10.1016\/j.mtbio.2026.103251_bib28","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1158\/2326-6066.CIR-19-0229","article-title":"STING signaling in melanoma cells shapes antigenicity and can promote antitumor T-Cell activity","volume":"7","author":"Falahat","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"15","key":"10.1016\/j.mtbio.2026.103251_bib29","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2013598118","article-title":"Epigenetic reprogramming of tumor cell\u2013intrinsic STING function sculpts antigenicity and T cell recognition of melanoma","volume":"118","author":"Falahat","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103251_bib30","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1158\/0008-5472.CAN-13-1703","article-title":"RAE1 ligands for the NKG2D receptor are regulated by STING-dependent DNA sensor pathways in lymphoma","volume":"74","author":"Lam","year":"2014","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103251_bib31","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"suppl_8","key":"10.1016\/j.mtbio.2026.103251_bib32","doi-asserted-by":"crossref","first-page":"viii1","DOI":"10.1093\/annonc\/mdx444","article-title":"Immunotherapy in ovarian cancer","volume":"28","author":"Odunsi","year":"2017","journal-title":"Ann. Oncol."},{"issue":"33","key":"10.1016\/j.mtbio.2026.103251_bib33","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1200\/JCO.21.00334","article-title":"Nivolumab versus gemcitabine or pegylated liposomal doxorubicin for patients with platinum-resistant ovarian cancer: open-label, randomized trial in Japan (NINJA)","volume":"39","author":"Hamanishi","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103251_bib34","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/annonc\/mdz135","article-title":"Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study","volume":"30","author":"Matulonis","year":"2019","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.mtbio.2026.103251_bib35","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.3390\/cancers12113301","article-title":"Immune checkpoint blockade in gynecologic cancers: state of affairs","volume":"12","author":"Drakes","year":"2020","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.mtbio.2026.103251_bib36","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41568-022-00503-z","article-title":"Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation","volume":"22","author":"Kandalaft","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"7776","key":"10.1016\/j.mtbio.2026.103251_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41586-019-1593-5","article-title":"Harnessing innate immunity in cancer therapy","volume":"574","author":"Demaria","year":"2019","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.mtbio.2026.103251_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba7589","article-title":"Self-assembled cGAMP-STING\u0394TM signaling complex as a bioinspired platform for cGAMP delivery","volume":"6","author":"He","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mtbio.2026.103251_bib39","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.5c00226","article-title":"Carriers multimerize STING protein fragments to activate type I interferon signaling in STING-deficient cancer cells","author":"Kaskow","year":"2025","journal-title":"Mol. Pharm."},{"issue":"7748","key":"10.1016\/j.mtbio.2026.103251_bib40","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41586-019-1000-2","article-title":"Structural basis of STING binding with and phosphorylation by TBK1","volume":"567","author":"Zhang","year":"2019","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.mtbio.2026.103251_bib41","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1093\/nar\/gky186","article-title":"A novel transcript isoform of STING that sequesters cGAMP and dominantly inhibits innate nucleic acid sensing","volume":"46","author":"Wang","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103251_bib42","article-title":"Engineering the immune adaptor protein STING as a functional carrier","volume":"4","author":"Sun","year":"2021","journal-title":"Adv. Therapeut."},{"issue":"15","key":"10.1016\/j.mtbio.2026.103251_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202200905","article-title":"Peptide-based cancer vaccine delivery via the STING\u0394TM-cGAMP complex","volume":"11","author":"He","year":"2022","journal-title":"Adv. Healthcare Mater."},{"issue":"24","key":"10.1016\/j.mtbio.2026.103251_bib44","article-title":"STING protein-based in situ vaccine synergizes CD4+ T, CD8+ T, and NK cells for tumor eradication","volume":"12","author":"He","year":"2023","journal-title":"Adv. Healthcare Mater."},{"issue":"12","key":"10.1016\/j.mtbio.2026.103251_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay3255","article-title":"Carboxylated branched Poly(\u03b2-Amino Ester) nanoparticles enable robust cytosolic protein delivery and CRISPR-Cas9 gene editing","volume":"5","author":"Rui","year":"2019","journal-title":"Sci. Adv."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103251_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202108116","article-title":"Tailoring hyperbranched Poly(\u03b2-Amino ester) as a robust and universal platform for cytosolic protein delivery","volume":"34","author":"Liu","year":"2022","journal-title":"Adv. Mater."},{"issue":"18","key":"10.1016\/j.mtbio.2026.103251_bib47","doi-asserted-by":"crossref","first-page":"21877","DOI":"10.1021\/acsami.3c01501","article-title":"Lipid nanoparticle delivery of small proteins for potent in vivo RAS inhibition","volume":"15","author":"Haley","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"17","key":"10.1016\/j.mtbio.2026.103251_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202500844","article-title":"Optimization of lipid nanoparticles with robust efficiency for the delivery of protein therapeutics to augment cancer immunotherapy","volume":"12","author":"Ren","year":"2025","journal-title":"Adv. Sci."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103251_bib49","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1021\/acscentsci.4c00071","article-title":"Bioreversible anionic cloaking enables intracellular protein delivery with ionizable lipid nanoparticles","volume":"10","author":"Alamgir","year":"2024","journal-title":"ACS Cent. Sci."},{"issue":"7956","key":"10.1016\/j.mtbio.2026.103251_bib50","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41586-023-05870-7","article-title":"Programmable protein delivery with a bacterial contractile injection system","volume":"616","author":"Kreitz","year":"2023","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103251_bib51","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","article-title":"Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins","volume":"185","author":"Banskota","year":"2022","journal-title":"Cell"},{"issue":"44","key":"10.1016\/j.mtbio.2026.103251_bib52","doi-asserted-by":"crossref","first-page":"10761","DOI":"10.1021\/ja0015388","article-title":"Degradable Poly(\u03b2-Amino esters): Synthesis, characterization, and self-assembly with plasmid DNA","volume":"122","author":"Lynn","year":"2000","journal-title":"J. Am. Chem. Soc."},{"issue":"18","key":"10.1016\/j.mtbio.2026.103251_bib53","doi-asserted-by":"crossref","first-page":"17799","DOI":"10.1021\/acsnano.3c03269","article-title":"Guanidyl-rich Poly(\u03b2 amino ester)s for universal functional cytosolic protein delivery and clustered regularly interspaced short palindromic repeats (CRISPR) Cas9 ribonucleoprotein based gene editing","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103251_bib54","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1021\/acsnano.9b09213","article-title":"Tuning nanoparticle interactions with ovarian cancer through layer-by-layer modification of surface chemistry","volume":"14","author":"Correa","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103251_bib55","article-title":"Surface avidity of anionic polypeptide coatings target nanoparticles to cancer-associated amino acid transporters","author":"Pires","year":"2025","journal-title":"bioRxiv"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103251_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10453","article-title":"Layer\u2010by\u2010layer Interleukin\u201012 nanoparticles drive a safe and effective response in ovarian tumors","volume":"8","author":"Barberio","year":"2023","journal-title":"Bioeng. Transl. Med."},{"issue":"11","key":"10.1016\/j.mtbio.2026.103251_bib57","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307802121","article-title":"Targeting and monitoring ovarian cancer invasion with an RNAi and peptide delivery system","volume":"121","author":"Hao","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103251_bib58","doi-asserted-by":"crossref","first-page":"11238","DOI":"10.1021\/acsnano.0c03109","article-title":"Cancer cell coating nanoparticles for optimal tumor-specific cytokine delivery","volume":"14","author":"Barberio","year":"2020","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103251_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10429","article-title":"Synergistic combination therapy delivered via layer-by-layer nanoparticles induces solid tumor regression of ovarian cancer","volume":"8","author":"Kong","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.mtbio.2026.103251_bib60","first-page":"1","article-title":"IL-12-Releasing nanoparticles for effective immunotherapy of metastatic ovarian cancer","author":"Pires","year":"2025","journal-title":"Nat. Mater."},{"key":"10.1016\/j.mtbio.2026.103251_bib62","author":"Larralde"},{"key":"10.1016\/j.mtbio.2026.103251_bib63","series-title":"Lehninger Principles of Biochemistry","author":"Nelson","year":"2005"},{"key":"10.1016\/j.mtbio.2026.103251_bib64","unstructured":"Bank, R. P. D. RCSB PDB - 4KC0: mSTING. https:\/\/www.rcsb.org\/structure\/4kc0 (accessed 2023-June-8)."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103251_bib65","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/pro.3280","article-title":"Improvements to the APBS biomolecular solvation software suite","volume":"27","author":"Jurrus","year":"2018","journal-title":"Protein Sci."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103251_bib66","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1021\/ct200133y","article-title":"Improved treatment of ligands and coupling effects in empirical calculation and rationalization of pKa values","volume":"7","author":"S\u00f8ndergaard","year":"2011","journal-title":"J. Chem. Theor. Comput."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103251_bib67","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1021\/j100058a043","article-title":"Accurate calculation of hydration free energies using macroscopic solvent models","volume":"98","author":"Sitkoff","year":"1994","journal-title":"J. Phys. Chem."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103251_bib68","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1021\/acs.biomac.4c00062","article-title":"Poly(\u03b2-Aminoester) physicochemical properties govern the delivery of siRNA from electrostatically assembled coatings","volume":"25","author":"Berger","year":"2024","journal-title":"Biomacromolecules"},{"issue":"5","key":"10.1016\/j.mtbio.2026.103251_bib69","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/S0006-3495(98)77976-7","article-title":"Quantitative fluorescence resonance energy transfer measurements using fluorescence microscopy","volume":"74","author":"Gordon","year":"1998","journal-title":"Biophys. J."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103251_bib70","first-page":"18.10.1","article-title":"Fluorescence resonance energy transfer: techniques for measuring molecular conformation and molecular proximity","volume":"57","author":"Edidin","year":"2003","journal-title":"Curr. Protoc. Im."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103251_bib71","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1158\/2159-8290.CD-20-0818","article-title":"Genetically defined syngeneic mouse models of ovarian cancer as tools for the discovery of combination immunotherapy","volume":"11","author":"Iyer","year":"2021","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103251_bib72","doi-asserted-by":"crossref","DOI":"10.1162\/15353500200403172","article-title":"Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden","volume":"3","author":"Paroo","year":"2004","journal-title":"Mol. Imaging"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103251_bib73","article-title":"Subcutaneous administration of D-Luciferin is an effective alternative to intraperitoneal injection in bioluminescence imaging of xenograft tumors in nude mice","volume":"2013","author":"Khalil","year":"2013","journal-title":"Int. Sch. Res. Not."},{"issue":"10","key":"10.1016\/j.mtbio.2026.103251_bib74","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/adma.201204346","article-title":"Degradable terpolymers with alkyl side chains demonstrate enhanced gene delivery potency and nanoparticle stability","volume":"25","author":"Eltoukhy","year":"2013","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103251_bib75","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1021\/acsbiomaterials.0c00271","article-title":"Efficiency of cytosolic delivery with Poly(\u03b2-Amino ester) nanoparticles is dependent on the effective pKa of the polymer","volume":"6","author":"Routkevitch","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.mtbio.2026.103251_bib76","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2021.05.047","article-title":"High-throughput evaluation of polymeric nanoparticles for tissue-targeted gene expression using barcoded plasmid DNA","volume":"337","author":"Kim","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103251_bib77","article-title":"\u201cTarget-and-Release\u201d nanoparticles for effective immunotherapy of metastatic ovarian cancer","author":"Pires","year":"2024","journal-title":"bioRxiv"},{"issue":"6604","key":"10.1016\/j.mtbio.2026.103251_bib78","doi-asserted-by":"crossref","DOI":"10.1126\/science.abm5551","article-title":"Massively parallel pooled screening reveals genomic determinants of nanoparticle delivery","volume":"377","author":"Boehnke","year":"2022","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.mtbio.2026.103251_bib79","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/s41591-018-0116-5","article-title":"Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses","volume":"24","author":"Ca\u00f1adas","year":"2018","journal-title":"Nat. Med."},{"issue":"28","key":"10.1016\/j.mtbio.2026.103251_bib80","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111003119","article-title":"STING activation promotes robust immune response and NK cell\u2013mediated tumor regression in glioblastoma models","volume":"119","author":"Berger","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103251_bib81","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.mtbio.2026.103251_bib82","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.mtbio.2026.103251_bib83","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11095-020-02818-8","article-title":"Tuning the physicochemical characteristics of particle-based carriers for intraperitoneal local chemotherapy","volume":"37","author":"Alavi","year":"2020","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103251_bib84","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200225","article-title":"Intraperitoneal carboplatin for ovarian cancer \u2014 a phase 2\/3 trial","volume":"2","author":"Nagao","year":"2023","journal-title":"NEJM Evid."},{"issue":"214","key":"10.1016\/j.mtbio.2026.103251_bib85","doi-asserted-by":"crossref","first-page":"ra20","DOI":"10.1126\/scisignal.2002521","article-title":"STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway","volume":"5","author":"Tanaka","year":"2012","journal-title":"Sci. Signal."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103251_bib86","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3390\/pharmaceutics15020638","article-title":"Liposomal delivery of MIW815 (ADU-S100) for potentiated STING activation","volume":"15","author":"Ji","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103251_bib87","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1038\/s41598-022-12449-1","article-title":"SHR1032, a novel STING agonist, stimulates anti-tumor immunity and directly induces AML apoptosis","volume":"12","author":"Song","year":"2022","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103251_bib88","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.str.2022.05.012","article-title":"Discovery of isonucleotidic CDNs as potent STING agonists with immunomodulatory potential","volume":"30","author":"Dejmek","year":"2022","journal-title":"Structure"},{"key":"10.1016\/j.mtbio.2026.103251_bib89","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2018.03.004","article-title":"PEG-PGA enveloped octaarginine-peptide nanocomplexes: an oral peptide delivery strategy","volume":"276","author":"Niu","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103251_bib90","first-page":"1","article-title":"The balance of STING signaling orchestrates immunity in cancer","author":"Lanng","year":"2024","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103251_bib91","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1021\/nn501197v","article-title":"Biodegradable polymeric nanoparticles show high efficacy and specificity at DNA delivery to human glioblastoma in vitro and in vivo","volume":"8","author":"Guerrero-C\u00e1zares","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103251_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118612","article-title":"Development of an optimized freeze-drying protocol for OM-PBAE nucleic acid polyplexes","volume":"569","author":"Fornaguera","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103251_bib93","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/s41565-024-01624-2","article-title":"Universal STING mimic boosts antitumour immunity via preferential activation of tumour control signalling pathways","volume":"19","author":"Wang","year":"2024","journal-title":"Nat. Nanotechnol."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426004953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426004953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:09:43Z","timestamp":1790064583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426004953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":92,"alternative-id":["S2590006426004953"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103251","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyelectrolyte nanoparticles enable intracellular delivery of STING protein fragments for ovarian cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103251"}}